Last reviewed · How we verify
Pseudoephedrine Sustained Action
Pseudoephedrine Sustained Action is a Small molecule drug developed by Washington University School of Medicine. It is currently FDA-approved. Also known as: Sudafed.
At a glance
| Generic name | Pseudoephedrine Sustained Action |
|---|---|
| Also known as | Sudafed |
| Sponsor | Washington University School of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Treatment of Acute Sinusitis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pseudoephedrine Sustained Action CI brief — competitive landscape report
- Pseudoephedrine Sustained Action updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI
Frequently asked questions about Pseudoephedrine Sustained Action
What is Pseudoephedrine Sustained Action?
Pseudoephedrine Sustained Action is a Small molecule drug developed by Washington University School of Medicine.
Who makes Pseudoephedrine Sustained Action?
Pseudoephedrine Sustained Action is developed and marketed by Washington University School of Medicine (see full Washington University School of Medicine pipeline at /company/washington-university-school-of-medicine).
Is Pseudoephedrine Sustained Action also known as anything else?
Pseudoephedrine Sustained Action is also known as Sudafed.
What development phase is Pseudoephedrine Sustained Action in?
Pseudoephedrine Sustained Action is FDA-approved (marketed).
Related
- Manufacturer: Washington University School of Medicine — full pipeline
- Also known as: Sudafed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing